Literature DB >> 22507416

Safety and efficacy of trisectionectomy for hepatocellular carcinoma.

Yanming Zhou1, Chengjun Sui, Bin Li, Tong Kan, Jiamei Yang, Mengchao Wu.   

Abstract

BACKGROUND: Right or left trisectionectomy represents the most extensive and difficult type of hepatic resection, and carries an unfavourably high morbidity and mortality. This retrospective study aimed to evaluate the safety and efficacy of trisectionectomy for hepatocellular carcinoma (HCC).
METHODS: From January 2000 to December 2008, 35 patients with HCC were treated with trisectionectomy. The treatment outcomes of these patients were retrospectively analysed.
RESULTS: Twenty-three right and 12 left trisectionectomies were performed. The overall operative morbidity and mortality were 42.8% (n= 15) and 2.8% (n= 1), respectively. The 1-, 3-, and 5-year overall survival rates were 82.9%, 51.4% and 23.8%, while the 1-, 3- and 5-year disease-free survival rates were 71.4%, 42.9% and 12.9%, respectively.
CONCLUSIONS: With careful patient selection and meticulous surgical technique, trisectionectomy can be performed safely and is associated with long-term survival in a subset of patients with HCC.
© 2011 The Authors. ANZ Journal of Surgery © 2011 Royal Australasian College of Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 22507416     DOI: 10.1111/j.1445-2197.2010.05605.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  6 in total

1.  Comparison of the Extent Classification and the New Complexity Classification of Hepatectomy for Prediction of Surgical Outcomes: a Retrospective Cohort Study.

Authors:  Xiao-Long Wu; Zhi-Yu Li; Yong Jiang; Xinyu Bi; Hong Zhao; Jian-Jun Zhao; Zhen Huang; Ye-Fan Zhang; Jian-Qiang Cai
Journal:  J Gastrointest Surg       Date:  2019-02-15       Impact factor: 3.452

2.  Adjuvant Intrahepatic Injection Iodine-131-Lipiodol Improves Prognosis of Patients with Hepatocellular Carcinoma After Resection: a Meta-Analysis.

Authors:  Ye Hong; Lu-Peng Wu; Feng Ye; Yan-Ming Zhou
Journal:  Indian J Surg       Date:  2015-05-23       Impact factor: 0.656

3.  Preoperative Antibiotic Prophylaxis Does Not Reduce the Risk of Postoperative Infectious Complications in Patients Undergoing Elective Hepatectomy.

Authors:  Yan-Ming Zhou; Zhen-Yi Chen; Xiu-Dong Li; Dong-Hui Xu; Xu Su; Bin Li
Journal:  Dig Dis Sci       Date:  2015-12-29       Impact factor: 3.199

4.  Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yan-Ming Zhou; Xiao-Feng Zhang; Bin Li; Cheng-Jun Sui; Jia-Mei Yang
Journal:  BMC Cancer       Date:  2015-10-14       Impact factor: 4.430

5.  Left hepatic trisectionectomy for hepatobiliary malignancies: Its' role and outcomes. A retrospective cohort study.

Authors:  Marcos Kostalas; Adam E Frampton; Nadeen Low; Rajiv Lahiri; Ee Jun Ban; Rajesh Kumar; Angela T Riga; Tim R Worthington; Nariman D Karanjia
Journal:  Ann Med Surg (Lond)       Date:  2019-11-29

6.  Meta-analysis: preoperative transcatheter arterial chemoembolization does not improve prognosis of patients with resectable hepatocellular carcinoma.

Authors:  Yanming Zhou; Xiaofeng Zhang; Lupeng Wu; Feng Ye; Xu Su; Lehua Shi; Bin Li
Journal:  BMC Gastroenterol       Date:  2013-03-19       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.